Outcomes Evaluation in Pulmonary Rehabilitation  for Patients with Cystic Fibrosis at Nationwide Children’s Hospital by Jacobson, Alice
  
 
Outcomes Evaluation in Pulmonary Rehabilitation  
for Patients with Cystic Fibrosis at Nationwide Children’s 
Hospital 
 
 
UNDERGRADUATE RESEARCH THESIS 
 
By 
Alice K. Jacobson, RRT, RCP 
Undergraduate Program in the Respiratory Therapy Division of the School of Health and 
Rehabilitation Science  
 
The Ohio State University 
2012 
 
 
Honor’s Committee: 
Advisor: Georgianna Sergakis, PhD, RRT, RCP 
Sarah Varekojis, PhD, RRT, RCP 
Emily Patterson, PhD 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright by 
Alice K. Jacobson, RRT, RCP 
2012 
 
 
 
ii 
 
 
 
 
 
Abstract 
  
INTRODUCTION: Pulmonary rehabilitation (PR) is an individualized program 
aimed at helping patients manage and cope with their symptoms.  Comprehensive PR 
includes education regarding pulmonary disorders, exercise training, nutrition classes, 
and psychosocial counseling.  Traditional PR programs for patients with chronic 
respiratory diseases such as COPD have shown positive outcomes.  In addition, physical 
activity has been shown to benefit cystic fibrosis (CF) patients.  As a result, PR may be a 
beneficial intervention for CF.  However, there are few centers that have designated 
programs for CF patients and there are no current studies describing the outcomes of 
pulmonary rehabilitation programs for CF patients.  The purpose of this research was to 
conduct an outcomes evaluation of an AACVPR-accredited PR program for CF patients.   
METHODS: The study examined clinical and psychosocial data of all CF patients that 
have participated in the program including pre and post 6-minute walk tests (6MW), 
pulmonary function tests (PFT), body mass index (BMI), and health-related quality of life 
(HRQOL).  It also examined if differences exist based on age, severity of disease, 
program compliance, and sex.    There was found to be a significant difference in pre/post 
6MW results (p = .001), and a significant difference in pre/post BMI values (p = .002).  
There was found to be a significant difference between pre and post 6MW distances for 
the varying levels of disease severity (F (5,27) = 2.838, p = 0.035), suggesting pulmonary 
rehabilitation may be more beneficial for CF patients with mild, moderate, or moderately-
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severe lung impairment.  Female patients were also shown to have a greater change in 
BMI from pre to post program than were male patients (F (1,34) = 4.160, p = 0.049).  
There was no significant change in the FEV1 and FEV1/FVC PFT values from pre to 
post program.  Tests on other variables were not performed due to incomplete records.  
CONCLUSIONS: Improvement in analyzed variables from pre to post PR, indicate that 
CF patients likely benefit from PR much like others with chronic respiratory diseases.   
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Chapter 1:  Introduction and Statement of the Problem 
 
Cystic fibrosis (CF) is a genetically inherited disease that causes the production of 
abnormally thick and sticky mucus which builds up in the lungs and the pancreas.  This 
buildup of mucus can lead to respiratory infections and digestion problems.  CF affects 
over 40,000 people in the United States and 70,000 people worldwide (Cystic Fibrosis 
Foundation, 2010).  In the past, people with CF rarely lived to attend elementary school; 
however over the past three decades, due to medical advancements, the average life 
expectancy for CF has increased to 37 years (Zieve & Hadjiliadis, 2011).  Although CF 
patients are living longer, they still face many chronic symptoms that affect their health 
status and quality of life.  Some symptoms include increased mucus production, recurrent 
pulmonary infections, inability to gain weight normally throughout childhood, fatigue, 
and increased sinus pressure.  There are many medical treatments available to CF patients 
that have been helpful in treating some of these symptoms. 
Mathews, et al emphasize that because cystic fibrosis is a genetically inherited 
disease, it is a lifelong condition.  The primary process of the condition that affects the 
lung is not the constitution of the mucus produced in the lungs; rather, it is the inability of 
the lungs to effectively clear the secretions.  The buildup of secretions in the lungs causes 
obstruction which impairs overall respiratory function.  The accumulation of secretions in 
the lungs invites bacterial growth which can cause increased impairment and inhibition of 
mucociliary clearance.  Bacterial growth causes chronic respiratory infections in CF 
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patients.  To treat and prevent mucus accumulation in the lungs chest physiotherapies are 
utilized to mobilize secretions and improve secretion clearance.  Physical activity has 
been important in prophylactically mobilizing secretions in day to day life as well as in 
the hospital settings (Mathews et al, 1964).  Physical activity and training has been found 
to help improve quality of life, and may slow the deterioration of lung function in 
pediatric patients as well (Bradley & Moran, 2008).   
Pulmonary rehabilitation has been defined as:  
“an evidence-based, multidisciplinary, and comprehensive intervention for 
patients with chronic respiratory diseases who are symptomatic
 
and often have 
decreased daily life activities. Integrated into
 
the individualized treatment of the 
patient, pulmonary rehabilitation
 
is designed to reduce symptoms, optimize 
functional status,
 
increase participation, and reduce health care costs 
through
 stabilizing or reversing systemic manifestations of the disease”(Nici et al, 
2006).   
According to Sharma, et al pulmonary rehabilitation helps to improve patients’ quality of 
life and maximize their capabilities.  Pulmonary rehabilitation is a tailored program 
aimed at helping patients cope and manage their symptoms (Sharma et al, 2010).  The 
program can include education regarding pulmonary disorders, exercise training, 
nutrition classes, and psychosocial counseling.  Research studies dating back to the mid-
1970s have shown that pulmonary rehabilitation programs have had success increasing 
exercise tolerance and quality of life in COPD patients by incorporating both exercise, 
education, and breathing retraining (Troosters et al, 2005).  Because of the known 
successes of traditional pulmonary rehabilitation programs geared toward patients with 
chronic respiratory diseases, such as COPD, and the known benefit of physical activity in 
CF patients, pulmonary rehabilitation is also a treatment for CF patients.  Though 
pulmonary rehabilitations programs might be beneficial for CF patients, there are few 
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centers that have a designated program for CF patients and there are no current studies 
describing the outcomes of pulmonary rehabilitation programs for CF patients.   
The purpose of this study was to perform an outcomes evaluation of a pulmonary 
rehabilitation program for cystic fibrosis patients at Nationwide Children’s Hospital in 
Columbus, Ohio.  The study examined clinical and psychosocial data of all CF patients 
that have participated in the program including pre and post 6-minute walk tests (6MW), 
pulmonary function test (PFT) results, body mass index (BMI), and health related quality 
of life (HRQOL).  This study also examined if differences exist based on age, severity of 
disease, program compliance, and sex. 
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Chapter 2: Related Research 
 
A literature search was conducted in Medline/ Pubmed and Academic Onefile 
databases using the keywords pulmonary rehabilitation, cystic fibrosis, and exercise.  The 
following is a review of current literature related to the proposed research.  In 2008, 
Bradley & Morgan conducted a review to determine if a prescribed exercise routine 
would help improve CF patients’ lung function and slow the deterioration of clinical and 
physiological symptoms.  The researchers reviewed all available literature, which totaled 
seven different studies, regarding physical exercise and its effects on CF patients. They 
found there is evidence that both aerobic and anaerobic physical training has positive 
effects on exercise capacity and lung function.  This is the evidence of both short term 
and long term studies that apply to the general CF patient population.  The review also 
provided some evidence that the beneficial effects from physical activity persist for a 
period of time even after the activity is stopped; however, the exact period of time is 
unknown.  The review ultimately supports that physical activity and training has been 
found to help improve quality of life and may slow the worsening of lung function in CF 
patients; additionally there is no evidence that physical activity and training should not be 
included in the care plan of CF patients (Bradley & Moran, 2008). 
Orenstein, et al conducted a study to determine the “effects of home-based, semi-
supervised, upper body strength training regimen with a similarly structured aerobic 
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training regimen” in CF patients.  Sixty seven patients ranging in age from 8-18 years 
were randomized into either an anaerobic training regimen using an arm ergometer with 
weight resistance or an aerobic training regimen with a stair stepper.  Patients were told 
to exercise three times a week for one year.  Measurements of pulmonary function, 
quality of life, strength, and aerobic fitness were recorded at baseline, 6 months, and 12 
months.  Neither aerobic nor anaerobic exercise proved to more beneficial than the other.  
However, there was a significant improvement in upper and lower body muscle strength 
for both aerobic and anaerobic exercise after 6 and 12 months. Additionally, patients 
engaging in both aerobic and anaerobic exercise over 6 and 12 months had a significant 
weight gain (Orenstein et al, 2004).  
A study performed by Nixon, et al aimed to study the prognostic value of exercise 
testing in CF patients.  The investigated revealed a strong correlation between survival of 
patients and aerobic fitness measured by V02 max.  The study also showed that after 
aerobic training patients have greater cardiovascular efficiency and ventilatory muscle 
strength.  The study also factored in the growth of P. cepacia in the lungs, which was 
found to be an independent cause of mortality in CF patients.  In CF patients that were 
not colonized with P. cepacia, lack of aerobic fitness was found to be the only significant 
independent cause of mortality.  The results support that exercise testing should be valued 
as a tool to evaluate CF patient prognosis; aerobic fitness was strongly correlated with 8 
year survival rates (Nixon et al 1992). 
Moeller, et al performed a study to examine the effects of a pulmonary 
rehabilitation program with components of exercise and chest physiotherapy on airway 
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inflammation in CF patients.  Eighteen patients with stable CF were obtained and 
enrolled in a three week inpatient rehabilitation program in Davos, Switzerland.  The 
patients’ symptoms were assessed at the beginning and end of the three weeks and were 
used to determine a clinical score based on the cystic fibrosis clinical score.  Patients 
were also assessed at baseline and post program by pulmonary function testing, exhaled 
breath condensate, and sputum analysis.  Throughout the three weeks the patients had 
twice daily inhaled treatments as well as chest physiotherapy administered by a 
healthcare professional.  They participated in an exercise program lead by a pediatric 
sports therapist.  The physical exam after the three weeks compared to the beginning of 
the three weeks resulted in an improved clinical score, as well as improved inspiratory 
capacities and forced vital capacities.  The study found no significant difference in the 
number of sputum cells or the sputum cytokines or markers within the three weeks.  The 
study ultimately provided evidence that a short term rehabilitation program for CF 
patients significantly improves subjective clinical symptoms as well as lung function in 
the FVC and IC, but has no effect on airway inflammation or obstruction Moeller et al, 
2010).   
A majority of the research about the effectiveness of pulmonary rehabilitation has 
been focused on the COPD patient population.  A 2004 study performed by the California 
Pulmonary Rehabilitation Collaborative Group sought to determine the outcomes of 
pulmonary rehabilitation programs in California in reducing dyspnea, improving quality 
of life, and reducing the utilization of healthcare resources by compiling patient 
assessment data from nine centers throughout California.  Of the patients that were 
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included in the study 93% of 522 total patients were diagnosed with COPD.  The study 
showed significant improvement in reduction of dyspnea and quality of life measures 
through a mean change in the Shortness of Breath Questionnaire measurements and the 
Physical Component Scores of the Medical Outcomes Short Survey Form.  The study 
also showed over 18 months of follow up that pulmonary rehabilitation programs led to a 
significant reduction in healthcare utilization including decreased hospitalization days, 
urgent care visits, physician office visits, and telephone calls to physicians (California 
Pulmonary Rehabilitation Collaborative Group, 2004).  
Reis, et al performed a study in 1995 to compare the physiological and 
psychosocial effects of providing solely education verses a comprehensive pulmonary 
rehabilitation program to patients with COPD.  The study took place at a university 
hospital with 119 stable COPD patients.  The patients were randomly assigned to either 
an 8 week education program or an 8 week pulmonary rehabilitation program; all patients 
were then tracked for 6 years.  Patients that were enrolled in the pulmonary rehabilitation 
program verses the education program has significant improvements in maximal exercise 
tolerance, maximal oxygen intake, breathlessness, muscle fatigue, and self-efficacy for 
walking.  There was no significant difference between the pulmonary rehabilitation 
patients and the education patients in lung function, quality of life, hospital days, or 
depression.  The patients enrolled in the pulmonary rehabilitation program did have an 
increased survival rate; however, it was not a significant difference from the patients that 
received purely education.  The results of the study strongly support the benefits obtained 
from pulmonary rehabilitation in the COPD patient population (Reis et al. 1995). 
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Griese et al. performed a retrospective chart review of rehabilitation data of cystic 
fibrosis patients in Israel, Germany, and Switzerland of 142 patients and 240 different 
rehabilitation stays.  The patients from Germany and Switzerland were combined in one 
group to compare to the patients in Israel who underwent rehabilitation in a different 
climate.  The study found that in both groups, patients’ weight and lung function did 
significantly improve in CF patients of all ages.  The rehabilitation sites in Israel found 
improvements in FVC and oxygen saturation, whereas the rehabilitation sites in Germany 
found improved FEV1 measurements.  However, this review was unable to compile 
various pieces of data and complete records because many of the pulmonary 
rehabilitation programs failed to collect and report all important pre and post patient data 
related to patient outcomes in the program.  The review does highlight the importance 
and need for pulmonary rehabilitation programs to track and maintain detailed records for 
necessary outcome analyses (Griese et al., 2010). 
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Chapter 3: Methodology 
Study and Research Objectives 
 The purpose of this study was to examine outcomes of the pulmonary 
rehabilitation program for patients with cystic fibrosis at Nationwide Children’s Hospital 
in Columbus, Ohio.    The following questions were addressed in this study: 
1.  Does a comprehensive pulmonary rehabilitation program for adult and pediatric 
patients with cystic fibrosis change outcomes including: 
a. health-related quality of life 
b. 6-minute walk distance   
c. body mass index 
d. pulmonary function  
2. Do outcomes for CF patients differ based on: 
a. age 
b. disease severity 
c. program compliance 
d. sex 
The Cardiopulmonary Rehabilitation Program at Nationwide Children’s 
The Cardiopulmonary rehabilitation program at Nationwide Children’s began in 
2005 and became the first pediatric American Association of Cardiovascular and 
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Pulmonary Rehabilitation (AACVPR) certified pulmonary rehabilitation program in 
2009.  Conditions that qualify for the program include obstructive lung disease such as 
CF, asthma; restrictive pulmonary disease; other pulmonary conditions, such as pre/post-
transplant, pulmonary hypertension, sickle cell disease; and cardiac conditions/diseases.  
However, this study focuses particularly on CF patients that participated in the program.  
A typical program lasts 6-8 weeks, meeting 2-3 times each week, with each session 
lasting 1.5-2 hours; however, the program can be extended on an individual basis, and 
some chronic patients can re-enrolled if need be.   
The program consists of a multidisciplinary team comprising physical therapy, 
therapeutic recreation/occupational therapy, massage therapy, nutrition, psychology, and 
education.  Physical therapy meets with the patients each visit working to improve 
cardiovascular endurance, increase chest mobility and improve breathing techniques, and 
to improve strength through upper and lower body strength training.  Therapeutic 
recreation with meet with a patient 2 times a week if the patient attends 3 sessions a 
week, or once a week if they attend 2 sessions a week.  Therapeutic recreation works with 
patients to help teach them to teach time management with health considerations, to help 
develop healthy leisure activities, to gain community resources, and to help manage 
stresses involved with participating in leisure activities.  Massage therapy meets with 
patients once a week to provide pain relief, relaxation, and increased circulation.  
Nutrition meets once a week with patients to analyze food recall for calories, fat, protein, 
vitamins and minerals in diet.  They provide individualized patient education and 
nutrition goals and will recommend supports for lifestyle and dietary changes.  
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Psychology meets once a week with patients to teach relaxation techniques to cope with 
symptoms and generally work to improve quality of life and mental status.  For CF 
patients, education is provided by a register respiratory therapist and can be given at any 
point during their program at least once.  Each of the areas of the Cardiopulmonary 
Rehabilitation program is tailored for each specific patient. 
In order to participate in the program at Nationwide Children’s patients need to be 
referred by an MD based on qualifying criteria.  Patients with certain disease/ conditions 
can be referred as listed above; patients can also be referred based on symptoms.  
Examples of physical symptoms include decrease in physical activity; decreased 
functional status; increased shortness of breath, dyspnea, and fatigue; decrease in 
pulmonary function; nutrition exhaustion or obesity.  Psychosocial symptoms could be 
reduced health related quality of life or disease effect on psychosocial status.  To 
additionally qualify for the program patients have to be greater than 4 years of age and 
able to communicate and follow directions.  Patients must also have reliable 
transportation and be willing to travel to the hospital’s main campus. 
The population in this study was the 41 total CF patients that have completed the 
pulmonary rehabilitation program to date at Nationwide Children’s Hospital in 
Columbus, OH.  This population includes both pediatric and adult patients. 
Study Design and Procedure 
A retrospective chart review was performed of all CF patients that completed the 
Pulmonary Rehabilitation program at Nationwide Children’s Hospital dating back to 
2005.  Patient data was reviewed at the patients’ baseline and then at the completion of 
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their pulmonary rehabilitation program.  The study compared pre and post program 
clinical and psychosocial data of CF patients in the program including physical training 
measured by pre and post 6MW distance, PFT results, BMI, health-related quality of life 
measured by responses on standardized instruments, and overall compliance with the 
program.  This study also examined if differences exist by age, severity of disease as 
measured by percent predicted FEV1, and compliance of the patients that participated in 
the program.  Program compliance was defined as completion of the pulmonary 
rehabilitation program. 
Statistical Analysis and Instrumentation 
A database was created using SPSS
®
 (Statistical Package for the Social Sciences) 
Version 19 containing the data collected via the survey instrument.  Dummy-coding was 
used to record nominal and ordinal data in an effort to facilitate statistical analysis.  Data 
was compiled from the medical records of CF patients pre-program and post-program.  
Health related quality of life (HRQOL) scores were evaluated through survey responses 
on standardized instruments.  The HRQOL survey instrumentation utilized by the 
program is the SF-36.  6MW tests are measurements of exercise capacity.  The test is 
measured by the total distance in feet a patient can walk in six minutes.  A pre and post 
weight and height was collected for all patients; this was then used to calculate a pre and 
post BMI (kg/m^2).  In order to determine the severity of the patients’ disease states pre 
and post data and PFT results were reviewed.  Pre and post PFT results were measured as 
close to the start and completion date of the program as possible; all collected PFT data 
were within three months before the start of the program and within three months after 
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completion.  The FEV1 % predicted values of the pre data were used to determine each 
patient’s severity of disease based on their obstruction.  Using Wilkin’s Egan’s 
Fundamentals of Respiratory Care patient were classified as either normal, mild, 
moderate, moderately-severe, severe, or very severe as demonstrated in the table below 
(Wilkins, 2009).   
 
Degree of Impairment 
FEV1 % 
predicted 
Normal 80%-120% 
Mild 70%-79% 
Moderate 60%-69% 
Moderately-Severe 50%-59% 
Severe 35%-49% 
Very Severe <35% 
Table 1: Severity of Disease Based on FEV1 % Predicted 
 
PFT results were also collected one year prior the start of the program and one year after 
completion of the program.  
Paired t-tests were used to analyze the pre and post differences to examine the 
changes following completion of the program.  ANCOVA tests were additionally used to 
test for covariate significance in changes of the pre/post data.  The alpha level was set a 
priori at 0.05.  A Bonferroni adjustment was made on alpha level threshold for the paired 
t-test to .025 (.05/2); this was to account for multiple tests performed. 
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Chapter 4: Results 
Study Population 
The 41 total CF patients that had been enrolled in the rehabilitation program since 
initiation were examined.  The patients’ ages ranged from 6 years to 56 years of age; 6 
total patients were pediatric patients, defined as younger than 18 years of age.  Eighteen 
patients were female, and 23 three were male.  Thirty one total patients were able to 
complete the program; the reasons for 10 patients’ incompletion of the program ranged 
from hospital admission, quick success in the program that made continuing unnecessary, 
dropping out of the program, death, or failure to participate in an exit evaluation.  Days in 
the program ranged from 21 to 363 days, with the mean length being 63.06 days.  Twelve 
patients were lung transplant patients; this includes both pre and post transplantation.  
Twenty four patients had a diabetes diagnosis.  Two patients were re-enrolled into 
pulmonary rehabilitation and both were added to the database.  Currently, 10 of the 
patients that underwent the pulmonary rehabilitation program are now deceased with 
death occurring from 1 to 36 months after rehabilitation. 
Results of Research Questions 
1. Does a comprehensive pulmonary rehabilitation program for adult and pediatric 
patients with cystic fibrosis change outcomes including: 
a. health-related quality of life 
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Though HRQOL data was collected, only 6 patients actually completed both 
pre and post survey data.  This was not a large enough portion of the study 
population to warrant a t-test analysis.  However, the descriptive data did 
reveal a change in the mean pre HRQOL scores to the mean post HRQOL 
score of 37.10 to 66.65, for the 6 total patients that completed both pre and 
post surveys.  A higher score indicates a higher of quality of life.  
The scores from a Shortness of Breath Questionnaire (SOBQ) were also 
collected.  However, too few patients completed both the pre and post 
questionnaire for apparent paired t-test.  The descriptive pre post data did 
reveal a change in the mean pre SOBQ score to the post SOBQ score of 
31.125 to 20.000, for the 16 total patients that completed both pre and post 
surveys.  A lower score indicates less shortness of breath. 
The number of hospital admissions 6 months prior and post program was 
collected for every patient possible.  Only 23 patients had both pre and post 
program records of hospitalizations within 6 months.  The  mean 
hospitalizations from pre-program to post program was 2.0 and 1.9 
respectively, for the 23 patient that had both pre and post data recorded. 
 
b. 6-minute walk distance 
33 patients completed both a pre and post 6MW test.  A paired t-test analyzed 
significant change in the distance walked.  There was found to be a 
statistically significant difference in the pre/post change of the 6MW test with 
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p = 0.001.  This shows a significant increase in distance walked in the 6MW 
from pre to post program.  The following is a table and figure demonstrating 
the pre/post change. 
 
  Pre    Post     
  Mean 
Standard 
Error Mean 
Standard 
Error p-value 
6MW 1379.5 63.324 1593.0 58.506 0.001 
*alpha threshold adjusted to .025 (.05/2) for multiple tests per Bonferroni correction 
Table 2: Paired t-test for Pre/Post 6MW 
 
 
Figure 1: Pre/Post Comparison of Mean 6MW Distance 
Statistically significant if p ≤ 0.025 
* 
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c. BMI  
Data was collected to calculate a pre and post program BMI value in kg/m^2 
for 36 total patients.  A paired t-test was used to evaluate change.  There was 
found to be a statistically significant difference in the pre/post change of the 
patients’ BMI with a p = 0.002.  This shows a significant gain the patients’ 
BMI from pre to post program. The following is a table and figure 
demonstrating the pre post change. 
 
  Pre    Post     
  Mean 
Standard 
Error Mean 
Standard 
Error p-value 
BMI 20. 0.795 21.1 0.766 0.002 
*Alpha threshold adjusted to  .025 (.05/2) for multiple tests per Bonferroni correction 
Table 3: Paired t-test for Pre/Post BMI 
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Figure 2: Pre/Post Comparison of Mean BMI 
  
d. pulmonary function  
To determine if there was an effect of the pulmonary rehabilitation program 
on lung function a pre/post t-test performed, the FEV1 and the FEV1/FVC to 
test for a significant change.  Transplant patients were excluded from this 
analysis to control for extraneous variables, such as a lung transplant and 
resulting side effects or outcomes, which could also affect lung function.  
There was not found to be a statistically significant pre/post change in either 
Statistically significant if p ≤ 0.025 
* 
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FEV1 or the FEV1/FVC.  For the FEV1 pre/post t-test p = 0.549; p = 0.786 
for the FEV1/FVC for the t-test. 
 
  Pre    Post     
  Mean 
Standard 
Error Mean 
Standard 
Error p-value 
FEV1 1.690 0.181 1.600 0.182 0.549 
FEV1/FVC 0.630 0.029 0.640 0.044 0.786 
*alpha threshold adjusted to .025 (.05/2) for multiple tests per Bonferroni correction 
Table 4: Paired t-test for Pre/Post FEV1 and FEV1/FVC 
 
2. Do outcomes for CF patients differ based on: 
a. age 
Due to a disproportionate number of adult patients compared to pediatric 
patients that completed the program, ANCOVA tests were not performed to 
determine if age had effect on change from pulmonary rehabilitation. 
b. disease severity 
An ANCOVA test was performed to determine if there was a significant 
difference between levels of disease severity on the pre/post change of the 
6MW distance using an alpha threshold of 0.05.  The pre/post interaction with 
the severity of disease was statistically significant (F (5,27) = 2.838, p = 
0.035).  There is a greater improvement in 6MW distance in the mild, 
moderate, and moderately severe levels of severity.  However, this result 
should be interpreted with caution due to the uneven disbursement of patients 
across the varying levels of severity; only two patients were mild, and one 
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patient was moderate.  The following figure demonstrates the pre/post 
changes in 6MW across the different levels of severity of disease. 
 
 
Figure 3: Effect of Severity of Disease on Pre/Post 6MW Using Estimated Marginal 
Means 
   
c. program compliance 
Due to incomplete records, ANCOVA tests were not performed to determine 
if compliance had an effect on the pre post program data.  
d. sex 
An ANCOVA was performed to determine if there was a significant 
difference between male and females on the change of BMI using an alpha ≤ 
0.05.  The pre/post interaction with sex was statistically significant (F (1, 34) 
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= 4.160, p = 0.049).  There is a greater gain in BMI between the pre and post 
data in females than in males.   
 
Figure 4: Effect of Sex on Pre/Post BMI Using Estimated Marginal Means 
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Chapter 5: Discussion 
Exercise Capacity and Endurance 
The significant change between the pre and post 6MW data for CF patients that 
engaged in the pulmonary rehabilitation program at Nationwide Children’s is an 
indication of an increase in exercise capacity and endurance.  Patients were able to walk a 
significantly greater distance after completion of the program compared to at the start in 
the same six minute interval of time.  It has been previously illustrated by Nixon in 1992 
that aerobic fitness is strongly correlated with 8 year survival rates in CF patients and 
though survival rates of the patients in the program have not been closely analyzed, 
exercise through pulmonary rehabilitation has been shown to be beneficial to this patient 
population evident by the significant change in walk distance.  This increase in exercise 
capacity and endurance in CF patients due to pulmonary rehabilitation is consistent with 
results from research studies dating back to the mid-1970s that have shown that 
pulmonary rehabilitation programs have had similar successes in increasing exercise 
tolerance in COPD patients (Troosters et al, 2005).  Increased exercise capacity could 
also lead to decreased dyspnea.  Compiled descriptive data of the scores from the pre and 
post SOBQ did show a positive change in reduced shortness of breath after completion of 
the program for the patients that did complete this survey.  This reduction of dyspnea is 
consistent with another shown benefit of pulmonary rehabilitation in the COPD 
population by the California Pulmonary Rehabilitation Collaborative Group in 2004. 
33 
 
Lung Function 
This study also examined if pulmonary rehabilitation caused some significant 
change in PFT results which are evidence of lung impairment and function.  This portion 
of the study excluded patients that received lung transplants to control for extraneous 
variables due to transplantation.  Because there was no significant change in FEV1 or 
FEV1/FVC values found between the pre and post data, this is an indication that lung 
impairment by obstruction was unaffected by pulmonary rehabilitation.  This supports 
research found Moeller et al. in 2010 that demonstrated in a short term inpatient 
rehabilitation program there was no significant effect of pulmonary rehabilitation on 
overall lung obstruction.  The pulmonary rehabilitation was also relatively short in length 
for most patients with a mean length of 63.06 days.  However, Moller et al. also found in 
2010 a significant change of FVC and IC in pre post data from a short term inpatient 
rehabilitation program.  Unfortunately IC data could not be collected in this study as 
Nationwide Children’s does not generally obtain an IC value.  Descriptive data was 
compiled for the FVC excluding transplant patients, and showed a decrease from pre-
program (2.6541) to post program (2.4841); paired t-tests were not performed.  This 
decrease is not consistent with previously published literature.  This study does not 
support that pulmonary rehabilitation positively or negatively affects lung function.  
However, as emphasized by Mathews et al. in 1964, CF is a genetically inherited, chronic 
disease with no known cure; therefore, it is reasonable that improved exercised capacity 
does not necessarily correlate with improved lung function in this patient population.  
However, this study did find there to be a significant difference between patients’ 
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improvement in exercise capacity based on the severity of their disease state determined 
based on lung function tests.  
 Patients’ severity of disease was classified based on their pre FEV1 % predicted 
PFT values into classifications of normal, mild, moderate, moderately-severe, severe, or 
very severe.  There was found to be a significant difference between pre and post 6MW 
distances for the varying levels of disease severity.  Patients with mild, moderate, and 
moderately-severe lung impairment had greater changes in their 6MW from pre to post 
program than patients with normal, severe, or very severe lung impairment.  Though this 
result should be interpreted with caution due to the uneven disbursement of patients 
across the varying classifications of severity; two patients had mild lung impairment, and 
one had moderate impairment, this demonstrates that pulmonary rehabilitation is most 
beneficial in patients with some deterioration of lung function, but not as beneficial in 
patients with normal, severe, or very severe lung impairment.  Patients with normal lung 
function are not in need of pulmonary rehabilitation such as patients with lung 
impairment.  Patients with severe or very severe lung function are patients that are 
probably in consideration for more drastic measures of treatment such as lung 
transplantation.  The increased severity of their disease could also impair patients’ 
engagement in the physical activities of pulmonary rehabilitation compared to patients 
with less lung function deterioration.   
Of the 17 patients in this study that fell into both the severe and very severe lung 
impairment categories, five of those patients died within 1 to 36 months, additionally, 3 
patients received lung transplantation.  Bradley, J., & Moran, F. published in 2008 that 
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physical exercise may slow the deterioration in lung function in CF patients.  Based on 
results from this study, if physical exercise does slow deterioration in lung function it is 
not as likely in patients currently suffering from severe or very severe lung impairment. 
BMI and Weight Gain 
A significant change in BMI from the pre to post data indicates that the program 
was successful in increasing patients’ weight, which is usually a goal for CF patients due 
to the general difficulties in gaining for weight for this patient population.  BMI was 
analyzed instead of weight because this study included both pediatric and adult patients; 
therefore height was a controlled variable, which is especially important in growing 
pediatric patients.  An increase in BMI could be attributed to various elements of the 
pulmonary rehabilitation program, such as physical therapy, therapeutic 
recreation/occupational therapy, nutrition, or education.  It is likely due to the 
multidisciplinary approach that helps these patients increase weight gain, by developing 
muscle mass, learning the proper foods to consume, and becoming educated in breathing 
techniques to conserve energy.  This statistically significant increase in BMI from pre to 
post program is supported by previous research published by Orenstein et al. in 2004 who 
found CF patients that engaged in either aerobic or anaerobic exercise had a significant 
increase in weight after 6 and 12 months of exercising.  This study found that females 
with CF increased their BMI pre to post program significantly more than males with CF 
that enrolled in the program.  This result shouldn’t discourage CF pulmonary 
rehabilitation programs from enrolling male patients; the male CF patients did show an 
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increase in BMI pre to post program.  Additionally there are other benefits of pulmonary 
rehabilitation for CF patients outside of weight gain. 
Heath Related Quality of Life 
 A primary goal of pulmonary rehabilitation is to improve patients’ functional and 
health related quality of life.  Like any patient with a chronic disease state, CF patients 
face hardships from their physical limitations which can lead to a deterioration of quality 
of life.  Nationwide Children’s pulmonary rehabilitation program aims to improve 
patients health related quality of life through physical training, to help patients physically 
cope with disease process, and through consultations with psychology to help patients 
mentally cope with symptoms and to generally improve their emotional mental status.  
There were insufficient pre and post HRQOL surveys collected from patients that 
completed the program available to run paired t-tests.  However, there was a difference 
between the pre (37.10) and post (66.65) mean survey score for the 6 patients that did 
complete both the pre and post surveys.  This promising increase in scores indicates that 
patients had an increase in health related quality of life after completion of the program.  
The improvement in quality of life in CF pulmonary rehabilitation patients is also 
supported in previous literature regarding improved quality of life in COPD pulmonary 
rehabilitation patients (Troosters et al, 2005).  Consistent with Griese’s et al. in 2010, 
struggle with poor record keeping, this study also supports the need for consistent and 
improved record keeping.  Improving health related quality of life is an important 
element of pulmonary rehabilitation that should be reexamined at Nationwide Children’s 
after a few years of improved documentation and record keeping.   
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Reduction of Hospital Admissions 
 As healthcare professionals, the government, and hospitals work to drive down 
healthcare costs, there has been a recent push to reduced readmission rates.  A primary 
goal of all pulmonary rehabilitation programs based on their definition has been to 
“reduce health care costs through stabilizing or reversing systemic manifestations of the 
disease” (Nici et al, 2006).  Therefore, in addition to the data collected to answer research 
question, the number of hospital admissions 6 months prior and post program was 
investigated for every patient.  The hospitalizations recorded were limited to admissions 
in Nationwide Children’s; admissions to outside hospitals were not recorded.  
Additionally, there was not data available to collect the number of hospitalizations for 
every patient; only 23 patient had both pre and post hospitalization data recorded.  There 
was only a slight decrease in mean hospitalizations from 2.00 pre-program, to 1.91 post 
program.  The change was slight so paired t-tests were not performed.    Hospitalizations 
and admissions are important data to collect by pulmonary rehabilitation programs.  Even 
a slight decrease in the number of hospitalization post pulmonary rehabilitation could be 
substantial in improved patient quality of life and reduced health care cost from hospital 
admission; this could be a great benefit of pulmonary rehabilitation with CF patients. 
Conclusion 
 Based on this study, it is recommended that Nationwide Children’s and all other 
pulmonary rehabilitation programs should keep consistent and complete records for all 
patients.  Based on the improved outcome measures found, this study demonstrates the 
benefits of pulmonary rehabilitation in the CF population.  Implications for clinical 
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practice could include the creation of more pulmonary rehabilitation programs aimed 
towards CF patients, increased referrals for CF patients to pulmonary rehabilitation 
programs, and increased insurance reimbursement for CF patients enrolled in pulmonary 
rehabilitation programs.  Ultimately, this study supports and recommends the use of 
pulmonary rehabilitation with CF patients.    
Recommendations for Future Research 
 Future studies should examine the HRQOL in CF patients enrolled in pulmonary 
rehabilitation, as well as examine the number hospitalizations of CF patient’s pre and 
post pulmonary rehabilitation.  Additional studies could also monitor the effects more 
closely of pulmonary rehabilitation in the recovery of lung transplant in CF patients. 
Limitations 
 Limitations to this study were incomplete records and inconsistencies in the 
program between patients, such data collected, duration of the program, and surveys 
completed.  An additional limitation was the population size, especially in the pediatric 
patient population. 
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